The smell of freshly toasted bread or a just-brewed cup of coffee comes from a chemical reaction called the Maillard reaction — the same process that browns a steak in a hot pan. Scientists have long known this reaction creates hundreds of different compounds, but what happens when those compounds reach your gut? A team of researchers in Germany decided to find out.
PD Dr. Jürgen Lassak from LMU Munich and Professor Michael Hellwig from TU Dresden led the study, published in the journal Food Chemistry. They focused on a compound called CML (short for Nε-carboxymethyllysine), a modified form of the amino acid lysine that forms in foods like browned bread, roasted coffee, and fried meat. Unlike ordinary amino acids, which the small intestine absorbs easily, modified versions like CML slip through undigested — meaning they reach the large intestine, where trillions of bacteria make their home.
The researchers discovered that a common gut bacterium, Escherichia coli (often called E. coli), can break down CML using an enzyme called SpeC. What surprised the team was how clever this turned out to be. "The bacteria do not need to develop entirely new tools for this task," Lassak explained. "Instead, they repurpose their existing repertoire in a creative way." Think of SpeC as a Swiss Army knife: it already had other jobs, but it turns out the enzyme can handle CML too — along with other chemically modified amino acids it was never specifically designed for.
Erica Aveta, who co-led the research alongside Patroklos Vougioukas, pointed out why this matters from an evolutionary standpoint. Such flexibility gives bacteria a head start when encountering new dietary compounds. If a compound becomes a regular part of the diet — say, through regularly eating browned foods — bacteria could gradually adapt and specialize.
The study also found hints that this breakdown process may connect to human health. Computer analysis suggested similar CML-processing abilities exist across many types of gut bacteria. The researchers noted possible links to conditions like bowel cancer, fatty liver disease, and hepatitis, though they emphasized these connections do not yet prove that CML breakdown directly causes or prevents disease.
"These links do not yet prove a cause-and-effect relationship," cautioned Hellwig. Still, the findings point toward a bigger picture: the food we eat, the microscopic passengers in our gut, and our long-term health may be more intertwined than scientists previously realized. Understanding those connections — step by step, study by study — is how medicine moves forward.